Search Videos and More
News
UCSF Urology Experts Present Innovative Research and Treatment at National Urology Conference
Uncovering mechanisms of resistance to treatment in prostate cancer and improving response to cellular therapies in bladder cancer, are among the topics UCSF clinicians discussed at the American Urological Association’s 2026 Annual Meeting.
News
Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV
Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
News
‘Every Time I Relapsed, There Would Be a New Course of Therapy’
He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.
News
UCSF Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers.
News
Katherine Van Loon Named Editor-in-Chief of JCO Global Oncology
Katherine Van Loon, MD, MPH, has been appointed as the next editor-in-chief of JCO Global Oncology (JCO GO), an American Society of Clinical Oncology (ASCO) journal.
Video
UCSF Osher Center Overview: Integrative Medicine’s Value for Providers and Patients
Sanford C. Newmark, MD, medical director of the UCSF Osher Center for Integrative Medicine, explains what integrative medicine is (hint: it’s neither “alternative medicine” nor homeopathy) and how referred patients can benefit from its proven techniques.
Video
High Risk for Breast Cancer: Methods and Schedules to Ensure Optimal Screening
Hematologist-oncologist Elham Vosoughi, MD, starts with an update on breast cancer stats, noting that incidence in the United States is increasing by 1% every year – with an even sharper rise for women under 50.
News
How a Tumor Marker for Ovarian Cancer May Help Treat the Deadliest Bladder Cancers
Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.
News
Inclusion of New Risk Factors Can Improve Prediction of Invasive Breast Cancer
UCSF researchers update Breast Cancer Surveillance Consortium model to account for BMI and other familial risk factors.
News
UCSF Health Reaches 15,000 Robotic Surgeries
UCSF Health has the busiest robotic surgery program in the UC health system and is the leading academic medical institution for robotic surgeries in the western U.S.
News
Study Finds Significant Chemical Exposures in Women With Cancer
In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher levels of these chemicals in their bodies.
News
UCSF Urology Experts Highlight Leadership in Innovative Research and Treatment at National Urology Conference
Using artificial intelligence (AI) to improve prediction of prostate cancer treatment response and biomarkers to enhance prostate cancer diagnosis were among the topics discussed by UCSF clinicians at the American Urological Association’s 2025 annual meeting.
News
Felix Feng, Giant in the Field of Prostate Cancer, Dies at 48
“Felix Feng was an exceptional scientist – a once-in-a-generation scientist – and his staggering intellect and scientific insights led to his remarkable scientific accomplishments,"
News
Prostate Cancer Study: More Health Benefits from Plant-Based Diet
Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts and olive oil, according to new research by UC San Francisco.
News
Engineered Receptors Help the Immune System Home in on Cancer
Most cancer treatments – from chemotherapies to engineered immune cells – have a host of side effects, in large part because they affect healthy cells in the body at the same time as targeting tumor cells
News
Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities
While regular screenings may decrease the chance of diagnosis of advanced breast cancer in some women and lead to a 20% reduction in breast cancer mortality, other women will be diagnosed with advanced breast cancer despite screening at regular intervals.
News
Novel Immunotherapy Combination Destroys Colorectal Liver Metastases
UCSF researchers disrupt tumor immune environment with LIGHT/anti-CTLA-4 therapy in preclinical models.
Video
Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up
Karen Goodwin, DO, covers everything from how to answer patients’ questions on mammogram frequency to how to counsel them on breast cancer prevention.
News
Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference...
News
UCSF Study Finds a Better Way to Screen for Breast Cancer
A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than automatically giving annual mammograms, can lower the chance of more advanced cancers, while still safely matching people to the amount of screening they need.
Document
Cancer Immunotherapy Toxicity Evaluation (CITE) Program
UCSF Health’s new Cancer Immunotherapy Toxicity Evaluation (CITE) Program is a valuable resource for both patient care and provider consults.
News
Vaccine Trial Aims to Prevent Cancer in People with Lynch Syndrome
Lynch syndrome affects about 1 in 279 people in the U.S. and significantly increases the lifetime risk of colorectal cancer and several other cancers. An estimated 95% of people with Lynch syndrome do not know they carry the mutation.
News
UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.
News
UCSF Radiation Oncologist Honored for Prostate Cancer Care and Research
American Society of Radiation Oncology celebrates Mack Roach, III, MD, for profound impact on patient treatment and leadership in cancer disparities treatment outcomes.
